[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,769,270
  • Shares Outstanding, K 356,568
  • Annual Sales, $ 5,101 M
  • Annual Income, $ -360,000 K
  • EBIT $ 477 M
  • EBITDA $ 916 M
  • 60-Month Beta 0.59
  • Price/Sales 1.11
  • Price/Cash Flow 9.54
  • Price/Book 0.88
  • Price/Earnings ttm 24.48
  • Earnings Per Share ttm 0.65
  • Most Recent Earnings $0.08 on 04/29/26
  • Next Earnings Date 07/29/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-3851 Ophthalmic Goods

    Medical Services

Options Overview Details

View History
  • Implied Volatility 41.18% (-2.16%)
  • Historical Volatility 33.95%
  • IV Percentile 8%
  • IV Rank 4.95%
  • IV High 187.31% on 11/19/25
  • IV Low 33.56% on 05/06/26
  • Expected Move (DTE 4) 0.51 (3.15%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 176
  • Volume Avg (30-Day) 195
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 4,857
  • Open Int (30-Day) 4,445
  • Expected Range 15.67 to 16.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.16
  • Number of Estimates 5
  • High Estimate $0.21
  • Low Estimate $0.14
  • Prior Year $0.07
  • Growth Rate Est. (year over year) +128.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.26 +6.03%
on 04/29/26
17.12 -5.49%
on 04/17/26
-0.36 (-2.18%)
since 04/08/26
3-Month
15.14 +6.87%
on 03/30/26
18.92 -14.46%
on 02/25/26
-0.82 (-4.82%)
since 02/06/26
52-Week
10.99 +47.22%
on 05/23/25
18.92 -14.46%
on 02/25/26
+4.68 (+40.70%)
since 05/08/25

Most Recent Stories

More News
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

Increased cutting speed of 25,000 cuts per minute 1 is designed to minimize retinal traction, 2 increase vitreous flow 1 and reduce infusion pressure...

BLCO : 16.18 (+1.70%)
Bausch + Lomb Announces Second R&D “Teach-in” Webinar

Event will feature detailed overviews of two innovative contact lens technologies with potential to redefine the standard of care

BLCO.TO : 22.11 (+2.84%)
BLCO : 16.18 (+1.70%)
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will deliver more than 40 scientific data...

BLCO.TO : 22.11 (+2.84%)
BLCO : 16.18 (+1.70%)
Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

BLCO : 16.18 (+1.70%)
Bausch + Lomb: Q1 Earnings Snapshot

Bausch + Lomb: Q1 Earnings Snapshot

BLCO : 16.18 (+1.70%)
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

Revenue of $1.244 Billion Revenue Grew 9% as Reported and 6% on a Constant Currency 1 Basis Compared to the First Quarter...

BLCO.TO : 22.11 (+2.84%)
BLCO : 16.18 (+1.70%)
Bausch & Lomb Reports Tomorrow With Analysts Already Resigned to Single-Digit Growth

Barchart Research What to Expect from BLCO Earnings BLCO Generated April 28, 2026 Current Price $15.72 EPS Estimate $$0.06 Consensus Rating Hold Average Move 4.21% Bausch & Lomb Reports Tomorrow With Analysts...

BLCO : 16.18 (+1.70%)
Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For

Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For

BLCO : 16.18 (+1.70%)
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

Drawing on more than two decades of scientific evidence, a comprehensive review synthesizes more than 20 human studies highlighting the potential role of certain B vitamins in supporting eye health to...

BLCO.TO : 22.11 (+2.84%)
BLCO : 16.18 (+1.70%)
Bausch + Lomb Releases 2025 Sustainability Impact Report

The Broader Perspective framework sets direction for long-term environmental and social impact

BLCO.TO : 22.11 (+2.84%)
BLCO : 16.18 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 17.08
2nd Resistance Point 16.70
1st Resistance Point 16.44
Last Price 16.18
1st Support Level 15.79
2nd Support Level 15.41
3rd Support Level 15.15

See More

52-Week High 18.92
Last Price 16.18
Fibonacci 61.8% 15.89
Fibonacci 50% 14.95
Fibonacci 38.2% 14.02
52-Week Low 10.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.